PLSE Oct 2024 7.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:48PM EDT. Market open.
| Previous close | 6.20 |
| Open | 6.50 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 7.50 |
| Expiry date | 2024-10-18 |
| Day's range | 6.20 - 6.50 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Business WirePulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering
HAYWARD, Calif., June 28, 2024--Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, announced today the preliminary results of its rights offering, which expired at 5:00 p.m., Eastern Time, on June 26, 2024 (the "Expiration Date").
Simply Wall St.A US$60m drop in the market cap of Pulse Biosciences, Inc. (NASDAQ:PLSE) is not what insiders like to see after purchasing shares recently
Key Insights Insiders appear to have a vested interest in Pulse Biosciences' growth, as seen by their sizeable...
- Simply Wall St.
President & CEO of Pulse Biosciences Burke Barrett Buys More Stock
Even if it's not a huge purchase, we think it was good to see that Burke Barrett, the President & CEO of Pulse...
© 2024 Yahoo. All rights reserved.